TU Operating Cash Flow (Statement)

Telus Corporation Ordinary Shares · Operating Cash Flow (Statement)

TU logo

TU Operating Cash Flow (Statement)

Latest reported$4.59B CAD
TU TTM Cash from Operations · CAD ($1.65B → $4.59B)
High-resolution chart · PNG

TU operating cash flow (statement) history

Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.

Telus Corporation Ordinary Shares Operating Cash Flow (Statement) — Trailing twelve months (TTM) (CAD)
Period endingOperating Cash Flow (Statement) (CAD)
4,593,974,000
4,417,974,000
4,444,974,000
4,391,974,000
4,752,000,000
4,974,000,000
4,847,000,000
5,084,000,000
4,959,000,000
4,688,000,000
4,499,000,000
4,311,000,000
4,304,000,000
4,437,000,000
4,811,000,000
4,562,000,000
4,571,000,000
4,565,000,000
4,369,000,000
4,525,000,000
4,118,000,000
4,336,000,000
4,574,000,000
4,370,000,000
4,616,000,000
4,314,000,000
3,927,000,000
4,046,000,000
3,964,000,000
4,010,000,000
4,058,000,000
4,089,000,000
4,156,000,000
4,076,000,000
3,947,000,000
3,700,000,000
3,599,000,000
3,365,000,000
3,219,000,000
3,350,000,000
3,336,000,000
3,387,000,000
3,542,000,000
3,596,000,000
3,615,000,000
3,527,000,000
3,407,000,000
3,216,000,000
3,263,000,000
3,115,000,000
3,246,000,000
3,223,000,000
3,104,000,000
3,185,000,000
3,219,000,000
3,268,000,000
3,175,000,000
2,920,000,000
2,550,000,000
2,494,000,000
2,535,000,000
2,525,000,000
2,546,000,000
2,474,000,000
2,375,000,000
2,704,000,000
2,904,000,000
3,026,700,000
3,198,800,000
2,799,500,000
2,819,000,000
2,889,700,089
2,735,399,469
3,344,600,369
3,171,700,000
3,101,499,408
2,840,100,141
2,591,199,444
2,803,700,000
2,861,500,038
2,984,599,985
2,859,299,945
2,914,600,000
2,723,400,352
2,877,101,005
2,678,400,819
2,538,100,000
2,339,199,627
2,350,699,562
2,332,399,114
2,144,000,000
2,097,900,486
2,043,500,005
1,853,000,500
1,742,000,000
1,581,401,521
1,329,400,748
1,534,300,415
1,398,600,764
1,643,999,723
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.